Accession Number:

ADA612377

Title:

Singapore-US Strategic Dialogue on Biosecurity

Descriptive Note:

Corporate Author:

PITTSBURGH UNIV MEDICAL CENTER BALTIMORE MD CENTER FOR HEALTH SECURITY

Personal Author(s):

• Gronvall, Gigi K.
• Ravi, Sanjana
• Morhard, Ryan
• Cicero, Anita
• Inglesby, Tom

Report Date:

2014-07-01

Pagination or Media Count:

23.0

Abstract:

Singapore is poised to be a critical partner to the US in minimizing biosecurity challenges in Southeast Asia. As a nation, it is vulnerable to both emerging infectious disease and potential terrorism in the region. In addition to its geographical importance within the Asia-Pacific region, Singapore is a rising powerhouse in biotechnology, having invested 13.2B in biotech RD from 2011-2015. As a result, it has become an attractive site for international biotechnology companies like Novartis, as well as world-class research universities. It is home to government and academic expertise capable of identifying and responding to biosecurity challenges. Its expertise is, in many ways, complementary to that of the US in these realms.

Descriptors:

• *BIOLOGICAL WARFARE AGENTS
• *GOVERNMENT(FOREIGN)
• *SECURITY
• *SINGAPORE
• *UNITED STATES GOVERNMENT
• HEALTH
• INFRASTRUCTURE
• LIFE SCIENCES
• SAFETY

Subject Categories:

• Government and Political Science
• Civil Defense
• Chemical, Biological and Radiological Warfare

Distribution Statement:

APPROVED FOR PUBLIC RELEASE